{"SPADE_UN_25511": {"basic": {"SPADE ID": "SPADE_UN_25511", "Peptide Name": "Elisidepsin, PM02734", "Sequence": "VTVVPXXXXVFXV", "Source": "", "Biological Activity": ["Anticancer"], "Target Organism": "Human lung adenocarcinoma NCI-H322(IC50=0.30±0.15µM),Human lung carcinoma A549(IC50=0.58±0.25µM),Human lung adenocarcinoma NCI-H3255(IC50=1.00±0.25µM),Human lung carcinoma NCI-H661(IC50=1.50±0.85µM),Human lung carcinoma H1299(IC50=2.80±0.85µM),Human lung carcinoma H1975(IC50=2.00±0.65µM),Human lung carcinoma H1650(IC50=>5µM),Human lung carcinoma NCI-H460(IC50=>5µM),Human prostate cancer DU145(IC50=1.26±0.4µM),Human breast adenocarcinoma MDA-MB-231(IC50=4.70±1.2µM),Human breast adenocarcinoma MDA-MB-361(IC50=1.25±0.3µM),Human breast adenocarcinoma MCF-7(IC50=8.00±2.7µM),Human colon adenocarcinoma Colo205(IC50=0.75±0.2µM),Human colon adenocarcinoma HT29(IC50=3.70±0.8µM),Human colon adenocarcinoma Colo205(IC50=6.10±2.1µM),Human colon adenocarcinoma HCT 116(IC50=7.20±2.2µM),Human epidermoid cancer Hep2(IC50=4.30±1.2µM),Human liver carcinoma SK-HEP-1(IC50=6.00±1.9µM),Human breast adenocarcinoma MDA-MB-435(IC50=4.40±0.9µM),Human ovarian adenocarcinoma IGROV1(IC50=4.20±0.8µM),Human epithelial carcinoma OVCAR-3(IC50=7.30±2.2µM),Human pancreatic adenocarcinoma CAPAN-1(IC50=5.00±1.6µM),Human pancreatic carcinoma Mia PaCa-2(IC50=8.80±3.1µM),Human prostate adenocarcinoma PC-3(IC50=1.80±0.4µM)", "Sequence Length": 13}, "extended_data_url": "SPADE_UN_25511_extended.json"}}